Modulation of HIV transmission by neisseria gonorrhoeae: Molecular and immunological aspects

Current HIV Research

Volumn 10, Issue 3, 2012, Pages 211-217

  Jarvis, Gary A ^a,b   Chang, Theresa L ^c,d  

^a SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

^d RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

GC HIV co infection; HIV transmission; Neisseria gonorrhoea

Indexed keywords

BETA INTERFERON; CHEMOKINE; CYTOKINE; DEFENSIN; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA;

CD4+ T LYMPHOCYTE; CYTOKINE PRODUCTION; DENDRITIC CELL; EXPERIMENTAL ANIMAL; EXPERIMENTAL MODEL; FEMALE GENITAL SYSTEM; GONORRHEA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOMODULATION; IN VITRO STUDY; MACROPHAGE; MOLECULAR BIOLOGY; NEISSERIA GONORRHOEAE; NONHUMAN; REVIEW; TARGET CELL; VIRUS INFECTIVITY; VIRUS TRANSMISSION;

EID: 84861118194     PISSN: 1570162X     EISSN: 18734251     Source Type: Journal    
DOI: 10.2174/157016212800618138     Document Type: Review

References (89)

1. Quinn TC, Overbaugh J. HIV/AIDS in women: an expanding epidemic. Science 2005; 308(5728): 1582-3.
2. Simon V, Ho DD, Abdool Karim Q. HIV/AIDS epidemiology, pathogenesis, prevention, and treatment. Lancet 2006; 368(9534): 489-504.
3. Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect 1999; 75(1): 3-17.
4. Galvin SR, Cohen MS. The role of sexually transmitted diseases in HIV transmission. Nat Rev Microbiol 2004; 2(1): 33-42.
5. Plummer FA. Heterosexual transmission of human immunodeficiency virus type 1 (HIV): interactions of conventional sexually transmitted diseases, hormonal contraception and HIV-1. AIDS Res Hum Retroviruses 1998, 14 Suppl 1: S5-10.
6. Cohen MS, Hoffman IF, Royce RA, et al. Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. AIDSCAP Malawi Research Group. Lancet 1997; 349(9069): 1868-73.
7. Chesson HW, Pinkerton SD. Sexually transmitted diseases and the increased risk for HIV transmission: implications for costeffectiveness analyses of sexually transmitted disease prevention interventions. J Acquir Immune Defic Syndr 2000; 24(1): 48-56.
8. Mabey D. Interactions between HIV infection and other sexually transmitted diseases. Trop Med Int Health 2000; 5(7): A32-6.
9. Rottingen JA, Cameron DW, Garnett GP. A systematic review of the epidemiologic interactions between classic sexually transmitted diseases and HIV: how much really is known? Sex Transm Dis 2001; 28(10): 579-97.
10. Coombs RW, Reichelderfer PS, Landay AL. Recent observations on HIV type-1 infection in the genital tract of men and women. Aids 2003; 17(4): 455-80.
11. Laga M, Manoka A, Kivuvu M, et al. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study. Aids 1993; 7(1): 95-102.
12. Grosskurth H, Mosha F, Todd J, et al. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial. Lancet 1995; 346(8974): 530-6.
13. McClelland RS, Wang CC, Mandaliya K, et al. Treatment of cervicitis is associated with decreased cervical shedding of HIV-1. Aids 2001; 15(1): 105-10.
14. Jin X, Chan S, Ding G, et al. Prevalence and risk behaviours for Chlamydia trachomatis and Neisseria gonorrhoeae infection among female sex workers in an HIV/AIDS high-risk area. Int J STD AIDS 2011; 22(2): 80-4.
15. Venkatesh KK, van der Straten A, Cheng H, et al. The relative contribution of viral and bacterial sexually transmitted infections on HIV acquisition in southern African women in the Methods for Improving Reproductive Health in Africa study. Int J STD AIDS 2011; 22(4): 218-24.
16. Kelley CF, Haaland RE, Patel P, et al. HIV-1 RNA rectal shedding is reduced in men with low plasma HIV-1 RNA viral loads and is not enhanced by sexually transmitted bacterial infections of the rectum. J Infect Dis 2011; 204(5): 761-7.
17. Bernstein KT, Marcus JL, Nieri G, Philip SS, Klausner JD. Rectal gonorrhea and chlamydia reinfection is associated with increased risk of HIV seroconversion. J Acquir Immune Defic Syndr 2010; 53(4): 537-43.
18. Edwards JL, Apicella MA. The molecular mechanisms used by Neisseria gonorrhoeae to initiate infection differ between men and women. Clin Microbiol Rev 2004; 17(4): 965-81.
19. Control cfd: Surveillance for gonorrhea and primary and secondary syphilis among adolescents, United States-1981-1991. Morbidity and mortality weekly report 1998; 42: 55-63.
20. Ramsey KH, Schneider H, Cross AS, et al. Inflammatory cytokines produced in response to experimental human gonorrhea. J Infect Dis 1995; 172(1): 186-91.
21. Klausner JD, Kohn R, Kent C. Etiology of clinical proctitis among men who have sex with men. Clin Infect Dis 2004; 38(2): 300-02.
22. [Densen P. Interaction of complement with Neisseria meningitidis and Neisseria gonorrhoeae. Clin Microbiol Rev 1989, 2 Suppl: S11-7.
23. Densen P, MacKeen LA, Clark RA. Dissemination of gonococcal infection is associated with delayed stimulation of complementdependent neutrophil chemotaxis in vitro. Infect Immun 1982; 38(2): 563-72.
24. Bolan G, Ehrhardt AA, Wasserheit JN. Gender perspectives and STDs, 3rd edn. New York, N.Y.: McGraw-Hill; 1999.
25. McGee ZA, Johnson AP, Taylor-Robinson D. Pathogenic mechanisms of Neisseria gonorrhoeae: observations on damage to human fallopian tubes in organ culture by gonococci of colony type 1 or type 4. J Infect Dis 1981; 143(3): 413-22.
26. Harvey HA, Post DM, Apicella MA. Immortalization of human urethral epithelial cells: a model for the study of the pathogenesis of and the inflammatory cytokine response to Neisseria gonorrhoeae infection. Infect Immun 2002; 70(10): 5808-15.
27. Fichorova RN, Desai PJ, Gibson FC, 3rd, Genco CA. Distinct proinflammatory host responses to Neisseria gonorrhoeae infection in immortalized human cervical and vaginal epithelial cells. Infect Immun 2001; 69(9): 5840-8.
28. Griffiss JM, Lammel CJ, Wang J, Dekker NP, Brooks GF. Neisseria gonorrhoeae coordinately uses Pili and Opa to activate HEC-1-B cell microvilli, which causes engulfment of the gonococci. Infect Immun 1999; 67(7): 3469-80.
29. Dehio C, Gray-Owen SD, Meyer TF. The role of neisserial Opa proteins in interactions with host cells. Trends Microbiol 1998; 6(12): 489-95.
30. Pridmore AC, Jarvis GA, John CM, Jack DL, Dower SK, Read RC. Activation of toll-like receptor 2 (TLR2) and TLR4/MD2 by Neisseria is independent of capsule and lipooligosaccharide (LOS) sialylation but varies widely among LOS from different strains. Infect Immun 2003; 71(7): 3901-8.
31. Hedges SR, Sibley DA, Mayo MS, Hook EW, 3rd, Russell MW. Cytokine and antibody responses in women infected with Neisseria gonorrhoeae: effects of concomitant infections. J Infect Dis 1998; 178(3): 742-51.
32. Liu M, John CM, Jarvis GA. Phosphoryl moieties of lipid A from Neisseria meningitidis and N. gonorrhoeae lipooligosaccharides play an important role in activation of both MyD88- and TRIFdependent TLR4-MD-2 signaling pathways. J Immunol 2010; 185(11): 6974-84.
33. Duncan JA, Gao X, Huang MT, et al. Neisseria gonorrhoeae activates the proteinase cathepsin B to mediate the signaling activities of the NLRP3 and ASC-containing inflammasome. J Immunol 2009; 182(10): 6460-69.
34. Levine WC, Pope V, Bhoomkar A, et al. Increase in endocervical CD4 lymphocytes among women with nonulcerative sexually transmitted diseases. J Infect Dis 1998; 177(1): 167-74.
35. Virji M, Watt SM, Barker S, Makepeace K, Doyonnas R. The Ndomain of the human CD66a adhesion molecule is a target for Opa proteins of Neisseria meningitidis and Neisseria gonorrhoeae. Mol Microbiol 1996; 22(5): 929-39.
36. Boulton IC, Gray-Owen SD. Neisserial binding to CEACAM1 arrests the activation and proliferation of CD4+ T lymphocytes. Nat Immunol 2002; 3(3): 229-36.
37. Ugolini S, Mondor I, Sattentau QJ. HIV-1 attachment: another look. Trends Microbiol 1999; 7(4): 144-9.
38. Haase AT. Early events in sexual transmission of HIV and SIV and opportunities for interventions. Annu Rev Med 2011, 62: 127-39.
39. Haase AT. Targeting early infection to prevent HIV-1 mucosal transmission. Nature 2010; 464(7286): 217-23.
40. Zhang Z, Schuler T, Zupancic M, et al. Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells. Science 1999; 286(5443): 1353-7.
41. Mattapallil JJ, Douek DC, Hill B, Nishimura Y, Martin M, Roederer M. Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection. Nature 2005; 434(7037): 1093-7.
42. [Schacker T, Little S, Connick E, et al. Productive infection of T cells in lymphoid tissues during primary and early human immunodeficiency virus infection. J Infect Dis 2001; 183(4): 555-62.
43. Southern PJ, Horbul JE, Miller BR, Maher DM. Coming of age: reconstruction of heterosexual HIV-1 transmission in human ex vivo organ culture systems. Mucosal Immunol 2011; 4(4): 383-96.
44. Hladik F, McElrath MJ. Setting the stage: host invasion by HIV. Nat Rev Immunol 2008; 8(6): 447-57.
45. [Pope M, Haase AT. Transmission, acute HIV-1 infection and the quest for strategies to prevent infection. Nat Med 2003; 9(7): 847-52.
46. de Witte L, Nabatov A, Pion M, et al. Langerin is a natural barrier to HIV-1 transmission by Langerhans cells. Nat Med 2007; 13(3): 367-71.
47. Anzala AO, Simonsen JN, Kimani J, et al. Acute sexually transmitted infections increase human immunodeficiency virus type 1 plasma viremia, increase plasma type 2 cytokines, and decrease CD4 cell counts. J Infect Dis 2000; 182(2): 459-66.
48. Nkengasong JN, Kestens L, Ghys PD, et al. Human immunodeficiency virus Type 1 (HIV-1) plasma virus load and markers of immune activation among HIV-infected female sex workers with sexually transmitted diseases in Abidjan, Cote d'Ivoire. J Infect Dis 2001; 183(9): 1405-8.
49. [Kaul R, Rowland-Jones SL, Gillespie G, et al. Gonococcal cervicitis is associated with reduced systemic CD8+ T cell responses in human immunodeficiency virus type 1-infected and exposed, uninfected sex workers. J Infect Dis 2002; 185(10): 1525-9.
50. Sheung A, Rebbapragada A, Shin LY, et al. Mucosal Neisseria gonorrhoeae coinfection during HIV acquisition is associated with enhanced systemic HIV-specific CD8 T-cell responses. Aids 2008; 22(14): 1729-37.
51. Chen A, Boulton IC, Pongoski J, Cochrane A, Gray-Owen SD. Induction of HIV-1 long terminal repeat-mediated transcription by Neisseria gonorrhoeae. Aids 2003; 17(4): 625-8.
52. Ding J, Rapista A, Teleshova N, et al. Neisseria gonorrhoeae Enhances HIV-1 Infection of Primary Resting CD4+ T Cells through TLR2 Activation. J Immunol 2010; 184(6): 2814-24.
53. Thibault S, Tardif MR, Barat C, Tremblay MJ. TLR2 signaling renders quiescent naive and memory CD4+ T cells more susceptible to productive infection with X4 and R5 HIV-type 1. J Immunol 2007; 179(7): 4357-66.
54. Ding J, Chang TL. TLR2 Activation Enhances HIV Nuclear Import and Infection through T Cell Activation-Independent and - Dependent Pathways. J Immunol 2011 Dec 30 [Epub ahead of print].
55. Dobson-Belaire WN, Cochrane A, Ostrowski MA, Gray-Owen SD. Differential response of primary and immortalized CD4+ T cells to Neisseria gonorrhoeae-induced cytokines determines the effect on HIV-1 replication. PLoS One 2011 6(4): e18133.
56. Zhang J, Li G, Bafica A, et al. Neisseria gonorrhoeae enhances infection of dendritic cells by HIV type 1. J Immunol 2005; 174(12): 7995-8002.
57. Thibault S, Fromentin R, Tardif MR, Tremblay MJ. TLR2 and TLR4 triggering exerts contrasting effects with regard to HIV-1 infection of human dendritic cells and subsequent virus transfer to CD4+ T cells. Retrovirology 2009; 6: 42.
58. de Jong MA, de Witte L, Oudhoff MJ, Gringhuis SI, Gallay P, Geijtenbeek TB.TNF-alpha and TLR agonists increase susceptibility to HIV-1 transmission by human Langerhans cells ex vivo. J Clin Invest 2008; 118(10): 3440-52.
59. [Dobson-Belaire WN, Rebbapragada A, Malott RJ, et al. Neisseria gonorrhoeae effectively blocks HIV-1 replication by eliciting a potent TLR9-dependent interferon-alpha response from plasmacytoid dendritic cells. Cell Microbiol 2010; 12(12): 1703-17.
60. Li Q, Estes JD, Schlievert PM, et al. Glycerol monolaurate prevents mucosal SIV transmission. Nature 2009; 458: 1034-8.
61. Wang Y, Abel K, Lantz K, Krieg AM, McChesney MB, Miller CJ. The Toll-like receptor 7 (TLR7) agonist, imiquimod, and the TLR9 agonist, CpG ODN, induce antiviral cytokines and chemokines but do not prevent vaginal transmission of simian immunodeficiency virus when applied intravaginally to rhesus macaques. J Virol 2005; 79(22): 14355-70.
62. Liu X, Mosoian A, Li-Yun Chang T, et al. Gonococcal lipooligosaccharide suppresses HIV infection in human primary macrophages through induction of innate immunity. J Infect Dis 2006; 194(6): 751-9.
63. Ganz T. Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol 2003; 3(9): 710-20.
64. Porter E, Yang H, Yavagal S, et al. Distinct defensin profiles in Neisseria gonorrhoeae and Chlamydia trachomatis urethritis reveal novel epithelial cell-neutrophil interactions. Infect Immun 2005; 73(8): 4823-33.
65. [Simhan HN, Anderson BL, Krohn MA, et al. Host immune consequences of asymptomatic Trichomonas vaginalis infection in pregnancy. Am J Obstet Gynecol 2007; 196(1): 59 e51-5.
66. Wiesenfeld HC, Heine RP, Krohn MA, et al. Association between elevated neutrophil defensin levels and endometritis. J Infect Dis 2002, 186(6):792-797.
67. Chang TL, Klotman ME. Defensins: natural anti-HIV peptides. AIDS Rev 2004; 6(3): 161-8.
68. Klotman ME, Chang TL. Defensins in innate antiviral immunity. Nat Rev Immunol 2006; 6(6): 447-56.
69. Quinones-Mateu ME, Lederman MM, Feng Z, et al. Human epithelial beta-defensins 2 and 3 inhibit HIV-1 replication. Aids 2003; 17(16): F39-48.
70. [Sun L, Finnegan CM, Kish-Catalone T, et al. Human {beta}- Defensins Suppress Human Immunodeficiency Virus Infection: Potential Role in Mucosal Protection. J Virol 2005; 79(22): 14318-29.
71. Klotman ME, Rapista A, Teleshova N, et al. Neisseria gonorrhoeae-Induced Human Defensins 5 and 6 Increase HIV Infectivity: Role in Enhanced Transmission. J Immunol 2008; 180(9): 6176-85.
72. Yang D, Biragyn A, Hoover DM, Lubkowski J, Oppenheim JJ. Multiple roles of antimicrobial defensins, cathelicidins, and eosinophil-derived neurotoxin in host defense. Annu Rev Immunol 2004; 22: 181-215.
73. Biragyn A, Ruffini PA, Leifer CA, et al. Toll-like receptor 4- dependent activation of dendritic cells by beta-defensin 2. Science 2002; 298(5595): 1025-9.
74. [Funderburg N, Lederman MM, Feng Z, et al. Human -defensin-3 activates professional antigen-presenting cells via Toll-like receptors 1 and 2. Proc Natl Acad Sci U S A 2007; 104(47): 18631-5.
75. Van Wetering S, Mannesse-Lazeroms SP, Van Sterkenburg MA, Daha MR, Dijkman JH, Hiemstra PS. Effect of defensins on interleukin-8 synthesis in airway epithelial cells. Am J Physiol 1997; 272(5 Pt 1): L888-96.
76. Guo CJ, Tan N, Song L, Douglas SD, Ho WZ. Alpha-defensins inhibit HIV infection of macrophages through upregulation of CCchemokines. Aids 2004; 18(8): 1217-8.
77. Boniotto M, Jordan WJ, Eskdale J, et al. Human beta-defensin 2 induces a vigorous cytokine response in peripheral blood mononuclear cells. Antimicrob Agents Chemother 2006; 50(4): 1433-41.
78. Liu CY, Lin HC, Yu CT, et al. The concentration-dependent chemokine release and pro-apoptotic effects of neutrophil-derived alpha-defensin-1 on human bronchial and alveolar epithelial cells. Life Sci 2007; 80(8): 749-58.
79. Narimatsu R, Wolday D, Patterson BK. IL-8 increases transmission of HIV type 1 in cervical explant tissue. AIDS Res Hum Retroviruses 2005; 21(3): 228-33.
80. Fellermann K, Stange EF. Defensins -- innate immunity at the epithelial frontier. Eur J Gastroenterol Hepatol 2001; 13(7): 771-6.
81. Svinarich DM, Wolf NA, Gomez R, Gonik B, Romero R. Detection of human defensin 5 in reproductive tissues. Am J Obstet Gynecol 1997; 176(2): 470-5.
82. Frye M, Bargon J, Dauletbaev N, Weber A, Wagner TO, Gropp R. Expression of human alpha-defensin 5 (HD5) mRNA in nasal and bronchial epithelial cells. J Clin Pathol 2000; 53(10): 770-3.
83. Jones DE, Bevins CL. Paneth cells of the human small intestine express an antimicrobial peptide gene. J Biol Chem 1992; 267(32): 23216-25.
84. Jones DE, Bevins CL. Defensin-6 mRNA in human Paneth cells: implications for antimicrobial peptides in host defense of the human bowel. FEBS Lett 1993; 315(2): 187-92.
85. Buckner LR, Schust DJ, Ding J, et al. Innate immune mediator profiles and their regulation in a novel polarized immortalized epithelial cell model derived from human endocervix. J Reprod Immunol 2011; 92(1-2): 8-20.
86. Rapista A, Ding J, Benito B, et al. Human defensins 5 and 6 enhance HIV-1 infectivity through promoting HIV attachment. Retrovirology 2011; 8(1): 45.
87. Ding J, Rapista A, Teleshova N, Lu W, Klotman ME, Chang TL. Mucosal human defensins 5 and 6 antagonize the anti-HIV activity of candidate polyanion microbicides. Journal of innate immunity 2011; 3(2): 208-12.
88. Fan SR, Liu XP, Liao QP. Human defensins and cytokines in vaginal lavage fluid of women with bacterial vaginosis. Int J Gynaecol Obstet 2008; 103(1): 50-4.
89. Kaul R, Kimani J, Nagelkerke NJ, et al. Monthly antibiotic chemoprophylaxis and incidence of sexually transmitted infections and HIV-1 infection in Kenyan sex workers: a randomized controlled trial. Jama 2004; 291(21): 2555-62.